Tuesday, 02 January 2024 12:17 GMT

Haemonetics To Present At Goldman Sachs 46Th Annual Global Healthcare Conference


(MENAFN- PR Newswire)

BOSTON, May 30, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE ) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 8:40 a.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link:

A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit .

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
(781) 356-9763
[email protected]

David Trenk, Manager-Investor Relations
(203) 733-4987
[email protected]

Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
[email protected]

SOURCE Haemonetics Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN30052025003732001241ID1109615354



Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search